Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Explor Res Clin Soc Pharm ; 14: 100432, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38550398

RESUMO

Pharmacy professionals report experiencing burnout and stress in the workplace. Concerns exist that burnout and stress in the pharmacy profession are having an impact on patient care and may be affecting the sustainability of the pharmacy profession. In response, pharmacy regulatory authorities worldwide are exploring how to address workplace wellness. Jurisdictions have varied in terms of the approaches taken, which range from surveys of pharmacy professionals, formation of committees or working groups, and legislative changes. The approach taken by the New Brunswick College of Pharmacists (NBCP) consisted of a literature review of the current state of pharmacy workplace wellness, an environmental scan of approaches to wellness taken in other jurisdictions, a workforce planning survey to gain insight into workplace wellness of pharmacy professionals, and the formation of a task force to make recommendations for improving workplace wellness of New Brunswick pharmacy professionals. Outlining the approach taken in New Brunswick, Canada provides insight that may help other pharmacy regulatory authorities who are considering, or in the process of, implementing a pharmacy workplace wellness initiative.

2.
Pharmacy (Basel) ; 10(6)2022 Nov 26.
Artigo em Inglês | MEDLINE | ID: mdl-36548315

RESUMO

Pharmacy practice continues to advance, allowing professionals to contribute further to patient care and the healthcare system. Pharmacists are authorized to perform point-of-care testing (POCT) in seven out of ten Canadian provinces. In considering the potential for enhanced clinical decision-making with the opportunity to gain patient data at the site of care, the New Brunswick College of Pharmacists (NBCP) proceeded to draft regulatory amendments and a policy to enable POCT scope in New Brunswick. Policy writing is a core function of Provincial Regulatory Authorities in Canada as the process determines principles that direct pharmacy practice. Each province has a differing scope of practice and method for developing documents. This paper highlights the approach, analysis, and findings of the NBCP pursuant to drafting a POCT policy. The policy development process included a literature search and environmental scan of the ten Canadian provincial regulatory authorities along with other countries. The findings highlighted in this paper describe the use of POCT, quality assurance, regulatory framework, educational opportunities, and the role of pharmacy technicians in relation to POCT in a pharmacy setting. The approach NBCP took to engage professionals and decisions on the direction of the policy are described. As point-of-care services continue to expand in pharmacies, the insights by the NBCP can be utilized by other regulatory bodies or pharmacy professionals who are implementing or enhancing POCT policies or procedures within their organizations.

3.
BMJ Qual Saf ; 2022 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-35552253

RESUMO

BACKGROUND: Documenting an indication when prescribing antimicrobials is considered best practice; however, a better understanding of the evidence is needed to support broader implementation of this practice. OBJECTIVES: We performed a scoping review to evaluate antimicrobial indication documentation as it pertains to its implementation, prevalence, accuracy and impact on clinical and utilisation outcomes in all patient populations. ELIGIBILITY CRITERIA: Published and unpublished literature evaluating the documentation of an indication for antimicrobial prescribing. SOURCES OF EVIDENCE: A search was conducted in MEDLINE, Embase, CINAHL and International Pharmaceutical Abstracts in addition to a review of the grey literature. CHARTING AND ANALYSIS: Screening and extraction was performed by two independent reviewers. Studies were categorised inductively and results were presented descriptively. RESULTS: We identified 123 peer-reviewed articles and grey literature documents for inclusion. Most studies took place in a hospital setting (109, 89%). The median prevalence of antimicrobial indication documentation was 75% (range 4%-100%). Studies evaluating the impact of indication documentation on prescribing and patient outcomes most commonly examined appropriateness and identified a benefit to prescribing or patient outcomes in 17 of 19 studies. Qualitative studies evaluating healthcare worker perspectives (n=10) noted the common barriers and facilitators to this practice. CONCLUSION: There is growing interest in the importance of documenting an indication when prescribing antimicrobials. While antimicrobial indication documentation is not uniformly implemented, several studies have shown that multipronged approaches can be used to improve this practice. Emerging evidence demonstrates that antimicrobial indication documentation is associated with improved prescribing and patient outcomes both in community and hospital settings. But setting-specific and larger trials are needed to provide a more robust evidence base for this practice.

4.
Explor Res Clin Soc Pharm ; 5: 100125, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35478507

RESUMO

Background: The experience for patients with mental health disorders may be negatively impacted by the barriers to care, such as low health care provider-to-population ratios, travel time to reach service providers, higher hospital readmission rates, and local demand for services, especially in suburban and rural areas. Objectives: The project aimed to design a model in which physicians and pharmacists collaborate to provide comprehensive care to patients with depression in two northern communities and improve the patient and provider experience. Methods: Pharmacists and primary care physicians developed a model in which patients starting on new antidepressant medications received regular follow-up care and education on adjunct therapies from the community pharmacists instead of the physician. The patient and provider experiences were measured through surveys. Results: Out of the 14 patients who completed the patient survey, 13 reported feeling more supported by receiving follow-up care from pharmacists. Out of the 5 providers who completed the provider survey, 4 reported that the physician-pharmacist collaboration and additional support were helpful to patients. Conclusion: Overall, the project positively impacted patient experience and providers perceived value in the shared-care model.

5.
Pharmacy (Basel) ; 9(2)2021 Apr 27.
Artigo em Inglês | MEDLINE | ID: mdl-33925675

RESUMO

To date, eight of ten Canadian provinces have authorized pharmacists to prescribe for minor ailments. Prompted by a request by the Ontario Minister of Health, draft regulations were submitted to enable this pharmacy service in Ontario. Differences exist in how jurisdictions have approached development and delivery of these programs. This paper will summarize key differences and similarities among existing programs while highlighting the multi-pronged approach utilized by Ontario. Such an approach involved broad stakeholder engagement, implementation science, and an evaluations framework to guide an assessment of the impact of this new service. These insights can be leveraged by other jurisdictions planning to initiate or evolve their minor ailment prescribing services.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA